18 - Human Microbiome and Disease Flashcards

(33 cards)

1
Q

Factors influencing microbial community composition

A
  • Environmental parameters filter diversity (e.g. oxygen tension, pH, temperature)
  • Interactions between microbes
  • Rapid evolution and speciation
  • Stochastic (unpredictable) forces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Interactions between microbes

A
  • Microbial communities comprise complex, interacting mixtures of bacteria, viruses, archaea, parasites, fungi
  • Competition and collaboration between microbes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Positive competition and collaboration between microbes

A

Cross feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Negative competition and collaboration between microbes

A

Bacteriocins that inhibit the growth of competing bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Impacting factors on gut microbiome

A
  • Diet
  • Pharmaceuticals
  • Geography
  • Lifecycle stages
  • Birthing process
  • Infant feeding method
  • Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

intestinal microbiota and food intake

A
  • Most complex plant polysaccharides are not digested by humans and enter the colon as a potential food source for the microbiota
  • Bacteria have diverse ability to break down different substrates
  • Change in diet can alter composition and resulting degradative activity of colonic microbiota
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example of geographical differences impacting microbiota

A
  • People of Japanese ancestry possess porphyranase enzymes in their gut microbiota which degrade sulfated polysaccharides found in edible seaweed (such as nori).
  • They can therefore harvest energy from seaweed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Human microbiota between individuals

A
  • HIghly variable within and between individuals
  • Each person has a microbiota that is distinct and relatively stable (but may be upset due to AB or diet)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

High bray curtis beta diversity score

A

More dissimilarity between samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bacterial succession

A

Predictable changes in bacterial community composition with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hysteresis

A

The phenomenon in which the value of a physical property lags behind changes in the effect causing it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Xenobiotic

A

A substance (often a synthetic chemical) that is foreign to the ecological system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Microbiota succession in early life

A
  • Shaped by the availability of different nutrients
  • In breastfed infants the gut microbiota is dominated by species (eg, Bifidobacteria) that metabolise human milk oligosaccharides.
  • Shifts in composition and enrichment of bacterial functions related to carbohydrate metabolism and the biosynthesis of amino acids and vitamins
  • By 2–3 years, a stable microbiota resembling that of the adults in the community
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When does colonisation first occur

A
  • Traces of bacterial DNA in placenta and amniotic fluid suggest prenatal colonization, but findings could be the result of contamination
  • First major exposure during delivery (difference in microbiota of vaginally born neonates compared to Caesarean section)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gut microbiome succession

A
  • Dominance of Enterobacteriaceae very early in life
  • Shift to balanced, stable microbiota over first 2 years
  • Breast fed (Bifidobacterium) vs formula fed (Bacteroides)
17
Q

Dysbiosis

A

An imbalance in a microbial community associated with disease

18
Q

Causes of dysbiosis

A
  • Bloom of pathobionts
  • Loss of commensals (e.g. antibiotic therapy) - often accompanied by pathen overgrowth
  • Loss of diversity (inflammatory bowel disease, HIV, diabetes)
19
Q

Example of loss of commensals

A

Clostridiodes difficile associated colitis

20
Q

Example of bloom of pathobionts

A

Enterobacteriaceae, in
inflammatory bowel disease

21
Q

Pathobiont

A

A potentially pathogenic organism which under normal circumstances lives as a symbiont

22
Q

Upper gastrointestinal tract vs lower

A

Acidic –> anaerobic and more neutral pH

23
Q

Positive effects of gut microbiome

A
  • Digestion and xenobiotic degradation
  • Immune system maturation and function
  • Brain development and behaviour
  • Protection and clearance of pathogens
24
Q

Dysbiosis of the gut microbiota and disease

A
  • Atherosclerosis
  • Allergies and autoimmune diseases
  • Diabetes
  • Inflammatory bowel disease
  • Neurodegeneration
  • Metabolic syndromes
25
Short chain fatty acids (SCFA)
- Produced by bacterial fermentation of indigestible polysaccharides - Make epithelial barrier less permeable through increased mucus production and tight junction expression - Also trigger release of hormones GLP-1 and PYY from enteroendocrine L cells
26
Examples of SCFA
- Propionate - Acetate - Butyrate
27
GLP-1 and PYY
- Regulat appetite by acting on the hypothalamus - GLP-1 is also potent promoter of glucose dependent insulin secretion (insulin sensitivity, which protects against diabetes)
28
L-carnitine and phosphatidylcholine
- Constituents of red meat - Metabolised by intestinal bacteria, releasing TMA - TMA is converted by liver enzymes to TMAO, which promotes atherosclerosis
29
Low mucus secretion of aberrant microbiota related to metabolic diseases
Results in 'leaky' epithelial barrier, which allows inflammatory PAMPs such as LPS to translocate, causing metabolic inflammation
30
Microbiota related to metabolic health pathway
SCFAs > Increase mucus secretion > Increase methane production > decrease luminal pH > decreases blood glucose > increases energy expenditure > increases glucose stimulated insulin secretion
31
Aberrant microbiota related to metabolic diseases pathway
Decrease mucus secretion > increase luminal pH > Increase Acetaldehyde > increase TMAO > Increase BG > increase Metabolic inflammation > decrease glucose stimulated insulin secretion
32
What does TMA stand for
Trimethylamine
33
What does TMAO stand for
Trimethylamine-N-oxide